Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Fact checked by Nick Blackmer Two Alzheimer's drugs that target amlyoid plaques have been approved for months, but many hospitals are only now starting to offer these treatments. Leqembi ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

Quality time takes on a whole new meaning after an Alzheimer's diagnosis. "We just finished a two-week European River cruise, ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...